MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Safety of opicapone in fluctuating Parkinson’s disease patients: Results of the 1-year extension of study BIPARK I

    A. Santos, J. Ferreira, A. Lees, F. Stocchi, O. Rascol, N. Lopes, H. Gama, J.F. Rocha, P. Soares-da-Silva (Porto, Portugal)

    Objective: Evaluate the safety of opicapone (OPC) in Parkinson's disease patients with motor fluctuations enrolled in the 1-year extension of study BIPARK I. Background: OPC,…
  • 2016 International Congress

    The efficacy of tremor detection and suppression device in intractable rest tremor in patients with Parkinson’s disease

    O. Jitkritsadakul, C. Thanawattano, C. Anan, R. Bhidayasiri (Bangkok, Thailand)

    Objective: This study was designed to determine the efficacy of the Tremor Detection and Suppression device (TDS) as a therapeutic option in PD patients with…
  • 2016 International Congress

    Apomorphine treatment in advanced Parkinson’s disease (PD): Duration of treatment and safety experience in a managed care program in Germany

    D. Maessen, G. Ebersbach, L. Timmermann, A. Ceballos-Baumann (Düsseldorf, Germany)

    Objective: To evaluate the duration of treatment (DOT) and safety of apomorphine continuous subcutaneous infusion (CSI) in patients with advanced PD inscribed in a managed…
  • 2016 International Congress

    Conversion to IPX066, extended-release carbidopa-levodopa, in advanced Parkinson’s disease patients: Dosing patterns

    J. Morgan, M. Stacy, R. Rubens, S. Khanna, S. Gupta (Augusta, GA, USA)

    Objective: Describe the dosing patterns in advanced Parkinson's disease (PD) patients who completed conversion to IPX066 from other levodopa formulations. Background: IPX066 is an extended-release…
  • 2016 International Congress

    Proprioceptive training as a means to enhance sensorimotor function in Parkinson’s disease

    N. Elangovan, P. Tuite, J. Konczak (Minneapolis, MN, USA)

    Objective: To identify whether proprioceptive function in Parkinson's disease (PD) can be enhanced by specialized visuomotor training that emphasizes precise movements and determine if such…
  • 2016 International Congress

    Feasibility and preliminary efficacy of a telehealth approach to group tango instruction for people with Parkinson’s disease

    K.J. Seidler, R.P. Duncan, M.E. McNeely, M.E. Hackney, G.M. Earhart (St. Louis, MO, USA)

    Objective: To determine the feasibility and preliminary efficacy of group adapted tango class for individuals with Parkinson's disease (PD) taught through telehealth technology. Background: Group…
  • 2016 International Congress

    Taking specialist clinics into community nursing homes

    T. Williams, S. Mahon, C. Thomas, B. Mohamed (Cardiff, United Kingdom)

    Objective: Evaluate the effectiveness of delivering specialist Parkinson's care in community care home settings. Background: Our drive to improve older people's care has led to…
  • 2016 International Congress

    LSVT-BIG© case studies: A snapshot of observations

    L.A. Dearle (Johannesburg, South Africa)

    Objective: This case presentation will outline two clients treated with LSVT –BIG and share some observations of the technique. Background: It is estimated that seven…
  • 2016 International Congress

    A crossover study of pretarsal and preseptal injections of botulinum toxin type A (BTX-A) in the treatment of hemifacial spasm and blepharospasm

    A. Choolam, K. Kulkantrakorn, P. Lolekha (Pathumthani, Thailand)

    Objective: To compare the efficacy, patient satisfaction, and side effects between pretarsal and preseptal injection sites on BTX-A treatment in abnormal orbicularis oculi contraction in…
  • 2016 International Congress

    Applicability study of a multitask cognitive and motor exercise program for individuals with Parkinson´s disease: The COGWEB CNS Move Program

    J. Domingos, D. Peralta, R. Loureiro, C. Ribeiro, V.T. Cruz, J. Ferreira (Torres Vedras, Portugal)

    Objective: To test the applicability of a new rehabilitation program for people with Parkinson´s disease combining web-based cognitive training with motor exercises. Background: Parkinson´s disease…
  • « Previous Page
  • 1
  • …
  • 114
  • 115
  • 116
  • 117
  • 118
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley